<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR941028-2-00220</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=26 g=1 f=3 --> Drug-susceptibility testing  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> On initial isolates <!-- PJG 0012 frnewline --> Radiometric methods <!-- PJG 0012 frnewline --> Reporting to public health department  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> Education and training <!-- PJG 0012 frnewline --> Emergency medical services <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> PPD screening program <!-- PJG 0012 frnewline --> Respiratory protection <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> Emergency departments  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> Management of patients <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=3 --> Endotracheal intubation  <!-- PJG 0012 frnewline --> Engineering controls  <!-- PJG 0012 frnewline --> Epidemiology, pathogenesis, and transmission of M. tuberculosis <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 -->  <!-- PJG 0012 frnewline --> Executive Summary <!-- PJG 0012 frnewline --> General ventilation <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> Dilution and removal <!-- PJG 0012 frnewline --> Facility airflow direction <!-- PJG 0012 frnewline --> Mixing factor <!-- PJG 0012 frnewline --> Negative pressure <!-- PJG 0012 frnewline --> Recirculating systems <!-- PJG 0012 frnewline --> Room airflow patterns <!-- PJG 0012 frnewline --> Short-circuiting <!-- PJG 0012 frnewline --> lSingle-pass systems <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> Glossary <!-- PJG 0012 frnewline --> Health-care facility, definition <!-- PJG 0012 frnewline --> Health-care worker(s) (HCW[s]) <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> Confidentiality <!-- PJG 0012 frnewline --> Counseling <!-- PJG 0012 frnewline --> Risk for infection <!-- PJG 0012 frnewline --> Risk for infection and disease in immunocompromised HCWs <!-- PJG 0012 frnewline --> Job reassignment <!-- PJG 0012 frnewline --> Definition <!-- PJG 0012 frnewline --> Education and training  <!-- PJG 0012 frnewline --> Evaluating PPD conversions <!-- PJG 0012 frnewline --> Evaluating positive PPD-test results <!-- PJG 0012 frnewline --> Immunocompromised <!-- PJG 0012 frnewline --> Preventive therapy <!-- PJG 0012 frnewline --> Screening for active TB <!-- PJG 0012 frnewline --> Screening for latent TB infection <!-- PJG 0012 frnewline --> Training <!-- PJG 0012 frnewline --> Workplace restrictions <!-- PJG 0012 frnewline --> Active TB <!-- PJG 0012 frnewline --> Latent TB infection <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> Health department <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> Case notification  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> Health Resources and Services Administration  <!-- PJG 0012 frnewline --> Heat wheel energy recovery units,  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> HEPA filtration for  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> Hierarchy of controls <!-- PJG 0012 frnewline --> High-efficiency particulate (HEPA) filtration <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> Autopsy rooms <!-- PJG 0012 frnewline --> Disposable prefilters to extend life <!-- PJG 0012 frnewline --> DOP penetration test <!-- PJG 0012 frnewline --> Efficiency <!-- PJG 0012 frnewline --> Enclosing booth use <!-- PJG 0012 frnewline --> In ambulatory-care areas <!-- PJG 0012 frnewline --> Individual room-air recirculation <!-- PJG 0012 frnewline --> Installation, maintenance, and monitoring <!-- PJG 0012 frnewline --> Longevity <!-- PJG 0012 frnewline --> Pressure-sensing device to determine replacement need <!-- PJG 0012 frnewline --> Recirculation of HEPA-filtered air within a room <!-- PJG 0012 frnewline --> Evaluation <!-- PJG 0012 frnewline --> Fixed room-air recirculation systems <!-- PJG 0012 frnewline --> Portable room-air recirculation units  <!-- PJG 0012 frnewline --> Recirculation of HEPA-filtered air to other areas of facility <!-- PJG 0012 frnewline --> Use when exhausting air to the outside <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> High-risk area <!-- PJG 0012 frnewline --> HIV infection <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> Anergy testing <!-- PJG 0012 frnewline --> Cell-mediated immunity, impaired <!-- PJG 0012 frnewline --> Chest radiography <!-- PJG 0012 frnewline --> Coinfection with  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> M. tuberculosis <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 -->  <!-- PJG 0012 frnewline --> Counseling HIV-infected HCWs <!-- PJG 0012 frnewline --> Evaluation of PPD skin-test results <!-- PJG 0012 frnewline --> Likelihood of infection after exposure to  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=3 --> M. tuberculosis <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 -->  <!-- PJG 0012 frnewline --> Progression from latent TB infection to active TB <!-- PJG 0012 frnewline --> Smears, AFB <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> Home-health-care settings <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> Cough-inducing procedures  <!-- PJG 0012 frnewline --> PPD screening program <!-- PJG 0012 frnewline --> Respiratory protection <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> Hospices <!-- PJG 0012 frnewline --> Human immunodeficiency virus (see HIV infection) <!-- PJG 0012 frnewline --> Infection control <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> Development of the TB infection-control plan <!-- PJG 0012 frnewline --> Engineering controls  <!-- PJG 0012 frnewline --> Evaluation of engineering controls <!-- PJG 0012 frnewline --> Fundamentals <!-- PJG 0012 frnewline --> Hierarchy of control measures  <!-- PJG 0012 frnewline --> Observation of infection-control practices <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=26 g=1 f=1 --> Infection-control practices, evaluating effectiveness  <!-- PJG 0012 frnewline --> Infectiousness <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=24 g=1 f=1 --> Determining <!-- PJG 0012 frnewline --> Factors determining  <!-- PJG 0012 frnewline --> In HIV-infected patients  <!-- PJG 0012 frnewline --> Length of, on therapy <!-- PJG 0012 frnewline --> Monitoring <!-- PJG 0012 frnewline --> Pediatric patients <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            